Please ensure Javascript is enabled for purposes of website accessibility Global Life Sciences Fund - Janus Henderson Investors
{{banner.link_text}}
For Individual Investors in the US

JNGLX Global Life Sciences Fund

The fund/portfolio seeks to harness the rapid innovation in health care to generate returns by investing in companies addressing unmet medical needs or those that seek to make the health care system more efficient.

Buy/Trade

NAV
$75.07
As of 11/20/2024

1-Day Change
$0.89 (1.20%)
 As of 11/20/2024

YTD Return
8.59%
As of 11/20/2024

Morningstar Rating

As of 10/31/2024

Morningstar Medalist Rating ™

Bronze Morningstar Analyst Rating
As of 10/07/2024

Overview

ABOUT THIS FUND

The fund seeks to harness the rapid innovation in health care to generate returns by investing in companies addressing unmet medical needs or those that seek to make the health care system more efficient.

WHY INVEST IN THIS FUND

Health Care Expertise: Our domain experts have 95+ years of combined experience investing in the complex and dynamic health care sector. Our team of specialists, which include multiple Ph.D.’s, seek to understand both the science and the business of prospective investments.

Balanced Approach: We diversify the portfolio across market capitalizations, geographies and the primary sub-sectors of health care, including investments in biotechnology, health care services, medical devices and pharmaceuticals.

Integrated Risk Management Process: Security-level “Value at Risk” framework focuses attention on downside risks by limiting the position size of higher-risk stocks.

Portfolio Management

Andy Acker, CFA
Andy Acker, CFA

Portfolio Manager

Industry since 1996. Joined Firm in 1999.

Daniel Lyons, Ph.D., CFA
Daniel Lyons, Ph.D., CFA

Portfolio Manager | Research Analyst

Industry since 2000. Joined Firm in 2000.

Performance

RETURNS (%) (As of 09/30/2024)
Global Life Sciences Fund - D Shares MSCI World Health Care IndexSM S&P 500® Index
 
3M YTD 1YR 3YR 5YR 10YR Since Inception
(12/31/1998)
Global Life Sciences Fund - D Shares 5.37 16.61 26.52 8.02 14.22 11.00 11.62
MSCI World Health Care IndexSM 5.70 14.14 20.84 6.52 11.61 8.96 7.07
S&P 500® Index 5.89 22.08 36.35 11.91 15.97 13.38 8.17
Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold.
High absolute short-term performance is not typical and may not be achieved in the future. Such results should not be the sole basis for evaluating material facts in making an investment decision.
Performance for Class D Shares that includes periods prior to 2/16/10 reflects the performance of one or more share classes of the Fund or a predecessor fund, adjusted, where applicable and permitted, for differing fees and expenses. See the Fund's prospectus for further details.

Returns include reinvestment of dividends and capital gains. Returns greater than one year are annualized.

RETURNS (%) (As of 10/31/2024)
Global Life Sciences Fund - D Shares MSCI World Health Care IndexSM S&P 500® Index
 
3M YTD 1YR 3YR 5YR 10YR Since Inception
(12/31/1998)
Global Life Sciences Fund - D Shares -0.73 12.79 30.33 5.28 12.28 10.15 11.44
MSCI World Health Care IndexSM -2.59 8.63 19.94 3.35 9.44 8.16 6.84
S&P 500® Index 3.66 20.97 38.02 9.08 15.26 13.00 8.10
Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold.
High absolute short-term performance is not typical and may not be achieved in the future. Such results should not be the sole basis for evaluating material facts in making an investment decision.
Performance for Class D Shares that includes periods prior to 2/16/10 reflects the performance of one or more share classes of the Fund or a predecessor fund, adjusted, where applicable and permitted, for differing fees and expenses. See the Fund's prospectus for further details.

Returns include reinvestment of dividends and capital gains. Returns greater than one year are annualized.

Calendar Year Returns (%)
Global Life Sciences Fund - D Shares MSCI World Health Care IndexSM
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Global Life Sciences Fund - D Shares 7.50 -2.70 6.82 25.55 29.20 4.34 22.59 -12.32 8.32 34.97
MSCI World Health Care IndexSM 3.76 -5.41 19.80 13.52 23.24 2.51 19.80 -6.81 6.60 18.10
Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold.
Performance for Class D Shares that includes periods prior to 2/16/10 reflects the performance of one or more share classes of the Fund or a predecessor fund, adjusted, where applicable and permitted, for differing fees and expenses. See the Fund's prospectus for further details.

Returns include reinvestment of dividends and capital gains. Returns greater than one year are annualized.

Returns-Based Statistics (As of 10/31/2024 Class D Shares)

RISK / REWARD
VS. MSCI World Health Care NR Index		 3YR 5YR
Information Ratio 0.36 0.43
Alpha 2.06 2.81
Tracking Error 5.25 6.15
Beta 1.02 1.00
R-squared (%) 89.32 85.22
UP/DOWN MARKET CAPTURE (%)
MSCI World Health Care NR Index		 3YR 5YR
Up Capture Ratio 107.51 102.52
Down Capture Ratio 98.06 90.38
STANDARD DEVIATION 3YR 5YR
Global Life Sciences Fund 15.66 15.94
MSCI World Health Care NR Index 14.39 14.69
SHARPE RATIO 3YR 5YR
Global Life Sciences Fund 0.09 0.61
MSCI World Health Care NR Index -0.03 0.47
Annual Fees & Expenses (As of the most recent prospectus)
CLASS D SHARES
Management Fees 0.64%
Other Expenses 0.16%
Total Gross Expenses 0.80%
Total Net Expenses 0.80%

Portfolio

Index represents the MSCI World Health Care Index.

Top Holdings (As of 10/31/2024)
% of Fund
Eli Lilly & Co 8.63
UnitedHealth Group Inc 6.78
Novo Nordisk A/S 4.46
AbbVie Inc 3.79
AstraZeneca PLC 3.53
Amgen Inc 3.41
Johnson & Johnson 2.80
Sanofi SA 2.66
Boston Scientific Corp 2.58
Vertex Pharmaceuticals Inc 2.46
TOTAL 41.10
View full holdings
Portfolio Characteristics (As of 10/31/2024)
  FUND INDEX
Number of Holdings
Equity Issues		 109 136
Market Capitalization
Weighted Average		 $201.79B $226.87B
Portfolio Turnover Rate
(1-year trailing)		 30.18% -
Price/Earnings Ratio
(1-year forward)		 19.53 17.81
Price/Book Ratio
 5.53 4.50
Earnings Growth Rate
(1-year forward)		 33.06% 22.96%
Sector Allocation % of Fund % of Index % of Fund % of Index As of 10/31/2024
Regional Allocation % of Fund % of Index % of Fund % of Index As of October 31, 2024
Developed vs Emerging Markets % of Fund % of Index % of Fund % of Index As of October 31, 2024
Market Capitalization Range of Equity Holdings % of Fund % of Index % of Fund % of Index As of 10/31/2024

Documents

Related Insights

Our intellectual capital is readily available and central to our Knowledge Shared approach"
Related Insights
Healthcare stocks shine in a dimming economy
Oct 3, 2024
Timely & Topical

Healthcare stocks shine in a dimming economy

The sector’s traditionally defensive qualities and accelerating innovation could stand out amid a potentially slowing economy.

8 min read

Shaping a Brighter Future: AI’s impact on healthcare
Sep 10, 2024
Timely & Topical

Shaping a Brighter Future: AI’s impact on healthcare

Hear how AI and other advances in healthcare are transforming patient outcomes and leading to new investment opportunities.

7 min read

Will a new candidate create volatility for healthcare stocks?
Aug 27, 2024
Timely & Topical

Will a new candidate create volatility for healthcare stocks?

Why we do not expect the last-minute change in the U.S. presidential election to lead to heightened volatility in healthcare stocks.

4 min read

Choose region

Country

Language

What type of investor are you?